Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Current Taxes data on file, last reported at $30.7 million in Q4 2025.

• In Q4 2025, Current Taxes fell 3.23% year-over-year to $30.7 million; the TTM figure through Dec 2025 stood at $30.7 million (down 3.23% YoY), while the FY2025 annual figure was $30.7 million, up 2.18% from the prior year.
• Current Taxes retreated to $30.7 million in Q4 2025, from $31.8 million in the prior quarter.
• Across five years, Current Taxes topped out at $31.8 million in Q4 2024 and bottomed at $12.5 million in Q4 2023.
• A 3-year average of $25.0 million and a median of $30.7 million in 2025 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes jumped 154.64% — and 2025, when it fell 3.23%.
• Year by year, Current Taxes stood at $12.5 million in 2023, then jumped by 154.64% to $31.8 million in 2024, then dropped by 3.23% to $30.7 million in 2025.
• The last three Current Taxes figures came in at $30.7 million (Q4 2025), $31.8 million (Q4 2024), and $12.5 million (Q4 2023), per Business Quant data.

Peer Comparison